
HHS Ends COVID-19 Emergency Use Authorizations, Shifting to Standard Regulation
HHS Secretary Robert F. Kennedy Jr. signed terminations ending the COVID-19 EUA declarations for drugs/biological products and for medical devices, with the terminations taking effect after advance notice (12 months for drugs; 180 days for devices). With traditional FDA pathways now widely available, reliance on EUA products will wind down, and regulators will aid manufacturers in pursuing standard approvals; notices will be published in the Federal Register and sent to Congress.










